» Articles » PMID: 7555952

Migrating Partial Seizures in Infancy: a Malignant Disorder with Developmental Arrest

Overview
Journal Epilepsia
Specialty Neurology
Date 1995 Oct 1
PMID 7555952
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Fourteen infants of both sexes had a previously unreported epileptic condition characterized by nearly continuous multifocal seizures. The first seizures occurred at a mean age of 3 months, without antecedent risk factors. At 1 to 10 months, the seizures became very frequent. They were partial with variable clinical expression, and the EEG showed that the discharges randomly involved multiple independent sites, moving from one cortical area to another in consecutive seizures. Although their topography varied, the EEG ictal pattern of each seizure was very similar. It consisted of rhythmic alpha or theta activity which spread to involve an increasing area of the cortical surface. Patients regressed developmentally and became quadriplegic with severe axial hypotonia. Three patients died at age 7 months and at age 7 and 8 years, respectively. Seizures were controlled in only 2 patients, and only 3 children resumed psychomotor development. Extensive investigation failed to determine an etiology, and there was no familial recurrence. Neuropathological examination of the brain in two cases showed only severe hippocampal neuronal loss and accompanying gliosis.

Citing Articles

Structure-Activity Relationship Studies in a Series of 2-Aryloxy--(pyrimidin-5-yl)acetamide Inhibitors of SLACK Potassium Channels.

Mishra N, Spitznagel B, Du Y, Mohamed Y, Qin Y, Weaver C Molecules. 2024; 29(23).

PMID: 39683653 PMC: 11643494. DOI: 10.3390/molecules29235494.


Perampanel reduces seizure frequency in patients with developmental and epileptic encephalopathy for a long term.

Yamagishi H, Osaka H, Muramatsu K, Kojima K, Monden Y, Mitani T Sci Rep. 2024; 14(1):30051.

PMID: 39627316 PMC: 11615398. DOI: 10.1038/s41598-024-82014-5.


Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels.

Qunies A, Spitznagel B, Du Y, Peprah P, Mohamed Y, Weaver C Molecules. 2024; 29(11).

PMID: 38893312 PMC: 11173529. DOI: 10.3390/molecules29112437.


Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.

Ng A, Chahine M, Scantlebury M, Appendino J J Neurol. 2024; 271(6):3063-3094.

PMID: 38607431 DOI: 10.1007/s00415-024-12352-x.


Genetic Background of Epilepsy and Antiepileptic Treatments.

Borowicz-Reutt K, Czernia J, Krawczyk M Int J Mol Sci. 2023; 24(22).

PMID: 38003469 PMC: 10671416. DOI: 10.3390/ijms242216280.